m+Medelevator.RU
← Поиск публикаций
Cancer cell · 2025

Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders.

Клиническое исследованиеСтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Yang Mao, Zhao Yuhao, Li Chen, Weng Xiaoling, Li Zhizhen, Guo Wu, Jia Wenning, Feng Feiling, Hu Jiaming, Sun Haonan, Wang Bo, Li Huaifeng, Li Ming, Wang Ting, Zhang Wei, Jiang Xiaoqing, Zhang Zongli, Liu Fubao, Hu Hai, Wu Xiangsong, Gu Jianfeng, Yang Guocai, Li Guosong, Zhang Hui, Zhang Tong, Zang Hong, Zhou Yan, He Min, Yang Linhua, Wang Hui, Chen Tao, Zhang Junfeng, Chen Wei, Wu Wenguang, Li Maolan, Gong Wei, Lin Xinhua, Liu Fatao, Liu Yun, Liu Yingbin

Аннотация

Gallbladder cancer (GBC) frequently mimics gallbladder benign lesions (GBBLs) in radiological images, leading to preoperative misdiagnoses. To address this challenge, we initiated a prospective, multicenter clinical trial (ChicCTR2100049249) and proposed a multimodal, non-invasive diagnostic model to distinguish GBC from GBBLs. A total of 301 patients diagnosed with gallbladder-occupying lesions (GBOLs) from 11 medical centers across 7 provinces in China were enrolled and divided into a discovery cohort and an independent external validation cohort. An artificial intelligence (AI)-based integrated model, GBCseeker, is created using cell-free DNA (cfDNA) genetic signatures, radiomic features, and clinical information. It achieves high accuracy in distinguishing GBC from GBBL patients (93.33% in the discovery cohort and 87.76% in the external validation cohort), reduces surgeons' diagnostic errors by 56.24%, and reclassifies GBOL patients into three categories to guide surgical options. Overall, our study establishes a tool for the preoperative diagnosis of GBC, facilitating surgical decision-making.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты